Preclinical pharmacokinetic (PK) and tumour growth inhibition (TGI) modelling for mANK-101

Preclinical pharmacokinetic (PK) and tumour growth inhibition (TGI) modelling for mANK-101

Hitesh Mistry, David Hodson, David Orrell, Sailaja Battula, Leisha A. Emens, Howard L. Kaufman, Michael M Schmidt, Christophe Chassagnole

Preclinical pharmacokinetic (PK) and tumour growth inhibition (TGI) modelling for mANK-101, an anchored murine interleukin-12 (IL-12) complex for intratumoural administration for solid cancer

Date

16th October 2023

Category

Posters